These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31390017)

  • 21. Prevention of embolism in elective cardioversion of atrial fibrillation.
    Mancini GB
    G Ital Cardiol; 1994 Mar; 24(3):331-40. PubMed ID: 8063069
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of embolism using calciparine during electrical cardioversion in atrial fibrillation.
    Portone AF; Pettinati G
    Minerva Cardioangiol; 1999 Jun; 47(6):191-4. PubMed ID: 10522144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioversion in Non-Valvular Atrial Fibrillation.
    Klein HH; Trappe HJ
    Dtsch Arztebl Int; 2015 Dec; 112(50):856-62. PubMed ID: 26763380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications.
    Fatkin D; Kuchar DL; Thorburn CW; Feneley MP
    J Am Coll Cardiol; 1994 Feb; 23(2):307-16. PubMed ID: 8294679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
    Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
    Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
    Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value and indications of transesophageal echocardiography before cardioversion of atrial fibrillation].
    Lesbre JP
    Arch Mal Coeur Vaiss; 2003 Sep; 96(9):871-9. PubMed ID: 14571641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation for cardioversion of atrial fibrillation.
    El Gendi H; Ismail T; Charalampos K; Mayet J
    Minerva Cardioangiol; 2002 Feb; 50(1):43-52. PubMed ID: 11830718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transesophageal echocardiography in the management of patients with atrial fibrillation].
    Kamenský G
    Bratisl Lek Listy; 1997 Nov; 98(11):583-8. PubMed ID: 9525048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
    Lip GY; Rumley A; Dunn FG; Lowe GD
    Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation].
    Baubion N
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
    Berger M; Schweitzer P
    Am J Cardiol; 1998 Dec; 82(12):1545-7, A8. PubMed ID: 9874066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of transesophageal echocardiography on the incidence of thromboembolism after electrical cardioversion in atrial fibrillation: A multicenter analysis.
    Shin DG; Mun HS; Lee HY; Hwang ES; Uhm JS; Pak HN; Lee MH; Joung B
    Int J Cardiol; 2016 Jan; 202():880-2. PubMed ID: 26476985
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute embolic myocardial infarction in a patient with paroxysmal atrial fibrillation receiving direct-current cardioversion.
    Lin TC; Hsieh YC; Lee WL; Lin YK; Ting CT; Wu TJ
    J Chin Med Assoc; 2009 Mar; 72(3):146-9. PubMed ID: 19299222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-step atrial thrombus exclusion and transesophageal cardioversion in atrial fibrillation.
    Mischke K; Schimpf T; Knackstedt C; Hanrath P; Schauerte P
    Expert Rev Med Devices; 2007 Jul; 4(4):549-57. PubMed ID: 17605690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABC of atrial fibrillation. Cardioversion of atrial fibrillation.
    Lip GY; Watson RD; Singh SP
    BMJ; 1996 Jan; 312(7023):112-5. PubMed ID: 8555897
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac Amyloidosis and the Risks of Cardioversion.
    Anderson KP
    J Am Coll Cardiol; 2019 Feb; 73(5):598-601. PubMed ID: 30732714
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardioversion of atrial fibrillation. State of the art, 1995.
    Rydén L; Malmberg K
    S Afr Med J; 1996 Jun; 86 Suppl 3():C152-8. PubMed ID: 8768779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.